pour la recherche uniquement
Réf. Catalogue: S3211
Structure chimique
| Poids moléculaire | 337.27 | Formule | C12 H17N4OS.HCl |
Stockage (À compter de la date de réception) | |
|---|---|---|---|---|---|
| N° CAS | 67-03-8 | Télécharger le SDF | Stockage des solutions mères |
|
|
| Synonymes | N/A | Smiles | CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-] | ||
|
In vitro |
Water : 67 mg/mL
DMSO
: Insoluble
Ethanol : Insoluble |
|
In vivo |
|||||
Étape 1 : Saisir les informations ci-dessous (Recommandé : Un animal supplémentaire pour tenir compte des pertes pendant l'expérience)
Étape 2 : Saisir la formulation in vivo (Ceci est seulement le calculateur, pas la formulation. Veuillez nous contacter d'abord s'il n'y a pas de formulation in vivo dans la section Solubilité.)
Résultats du calcul :
Concentration de travail : mg/ml;
Méthode de préparation du liquide maître DMSO : mg médicament prédissous dans μL DMSO ( Concentration du liquide maître mg/mL, Veuillez nous contacter d'abord si la concentration dépasse la solubilité du DMSO du lot de médicament. )
Méthode de préparation de la formulation in vivo : Prendre μL DMSO liquide maître, puis ajouterμL PEG300, mélanger et clarifier, puis ajouterμL Tween 80, mélanger et clarifier, puis ajouter μL ddH2O, mélanger et clarifier.
Méthode de préparation de la formulation in vivo : Prendre μL DMSO liquide maître, puis ajouter μL Huile de maïs, mélanger et clarifier.
Note : 1. Veuillez vous assurer que le liquide est clair avant d'ajouter le solvant suivant.
2. Assurez-vous d'ajouter le(s) solvant(s) dans l'ordre. Vous devez vous assurer que la solution obtenue, lors de l'ajout précédent, est une solution claire avant de procéder à l'ajout du solvant suivant. Des méthodes physiques telles que le vortex, les ultrasons ou le bain-marie chaud peuvent être utilisées pour faciliter la dissolution.
| In vitro |
Thiamine HCl (Vitamin B1) (50 mM), in addition to its nutritional value, induces systemic acquired resistance (SAR) in rice, tobacco, cucumber, and Arabidopsis. It also confers resistance to fungal, bacterial, and viral infections in treated rice, Arabidopsis (Arabidopsis thaliana), and vegetable crop plants. This compound induces the transient expression of pathogenesis-related (PR) genes in rice and other plants, and potentiates stronger and more rapid PR gene expression along with up-regulation of protein kinase C activity. At a concentration of 10 μM, it prevents acetaldehyde-induced inhibition of myocyte shortening in adult rat ventricular myocytes, effectively blunts the acetaldehyde-induced depression in ±dL/dt, and prevents acetaldehyde-induced shortening of time-to-peak shortening. Furthermore, it inhibits acetaldehyde-induced elevation in both protein carbonyl formation and caspase-3 activation in adult rat ventricular myocytes. Its uptake is energy- and temperature-dependent, pH-sensitive, Na+-independent, and saturable at both the nanomolar (apparent Km, 30 nM) and the micromolar (apparent Km, 1.72 mM) concentration ranges in ARPE-19 cells. Uptake of this compound is adaptively regulated by extracellular substrate level via transcriptionally mediated mechanisms that involve both hTHTR-1 and hTHTR-2 in ARPE-19 cells, and is also regulated by an intracellular Ca2+-calmodulin-mediated pathway. Thiamine-responsive megaloblastic anemia (TRMA) fibroblasts are rescued from death with 10 nM-30 nM of it (in the range of normal plasma thiamine concentrations). Normal fibroblasts exhibit saturable, high-affinity thiamine uptake (Km 400 nM-550 nM; Vmax 11 pmol/min/1×106 cells), while TRMA fibroblasts lack detectable high-affinity uptake. At 30 nM, the rate of its uptake by TRMA fibroblasts is 10-fold less than that of wild-type, which explains the increased apoptosis of TRMA fibroblasts.
|
|---|---|
| In vivo |
Thiamine HCl (Vitamin B1) deficiency results in amyloid precursor protein immunoreactivity accumulated in swollen neurites within, or around lesions in rats, or in abnormal clusters in mice.
|
Références |
|
| Méthodes | Biomarqueurs | Images | PMID |
|---|---|---|---|
| Western blot | THICL / THICS / THI4L / THI4M / THI4S / ACT Bax / Bid / p53 / p84 Rpb1 / Fcp1 / f-Rpb3 / Tfg3 / Rpb7 / Rpb4 |
|
18093957 |
| Growth inhibition assay | TEN1 and TEAEN1 strains hippocampal Dcx+ cells |
|
19028995 |
| Glycolysis stress test | Glycolysis stress |
|
29914147 |
| Cell death | Cell survival |
|
31193162 |
| Western blot / RNA Blot | PR-1 / rRNA PR-1 / rRNA |
|
15980201 |
| Immunofluorescence | Thi76KR / Thi7M399R / ThiN350K |
|
31658248 |
(données du https://clinicaltrials.gov, mis à jour le 2026-08-28)
| Numéro NCT | Recrutement | Conditions | Promoteur/Collaborateurs | Date de début | Phases |
|---|---|---|---|---|---|
| NCT07793071 | NOT_YET_RECRUITING | Major Depressive Disorder (MDD); Thiamine; Vitamin B1; Thiamine Diphosphate (TDP); Pediatrics |
Massachusetts General Hospital |
2026-10-01 | PHASE2 |
| NCT07795996 | RECRUITING | Neurocognition, Child |
Mount Saint Vincent University |
2026-06-01 | |
| NCT06649825 | ENROLLING_BY_INVITATION | Familial Adenomatous Polyposis (FAP) |
Shanghai Zhongshan Hospital |
2024-01-08 | |
| NCT06959251 | RECRUITING | Primary Ciliary Dyskinesia |
Instituto Nacional de Enfermedades Respiratorias |
2025-10-02 | |
| NCT05817851 | RECRUITING | Cardiac Arrest |
Centre Hospitalier de Bethune |
2023-12-27 | PHASE2 |
| NCT07708233 | RECRUITING | Diabetic Peripheral Neuropathy (DPN) |
Thammasat University |
2026-07-14 | PHASE4 |